Skip Navigation



Home » Drug Information » FDA Approved Drugs » 1997
Medical Areas: Musculoskeletal | Rheumatology

View By:YearCompanyConditionsTherapeutic AreasDrug Names


The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Schein Pharmaceutical
Approval Status: Approved December 1997
Treatment Area: anti-inflammatory

General Information

Ketoprofen, the generic equivalent of Wyeth Ayerst's Oruvail, has received approval as a non-steroidal anti-inflammatory. Ketoprofen will be available in 200 mg extended release capsules.